Aadi Bioscience Inc (AADI)
1.815
-0.06
(-2.94%)
USD |
NASDAQ |
May 10, 12:25
Aadi Bioscience Total Liabilities (Quarterly): 27.23M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 27.23M |
| September 30, 2023 | 21.46M |
| June 30, 2023 | 19.81M |
| March 31, 2023 | 24.67M |
| December 31, 2022 | 25.86M |
| September 30, 2022 | 25.00M |
| Date | Value |
|---|---|
| June 30, 2022 | 19.91M |
| March 31, 2022 | 17.69M |
| December 31, 2021 | 21.50M |
| September 30, 2021 | 17.85M |
| December 31, 2020 | 31.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.69M
Minimum
Mar 2022
31.26M
Maximum
Dec 2020
22.93M
Average
21.50M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 163.90M |
| 89bio Inc | 59.96M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.42M |
| Shareholders Equity (Quarterly) | 105.20M |
| Current Ratio | 4.720 |